Hopman Mark
Hopman Mark, CCO, reported an open-market or private sale at Beta Bionics, Inc. involving 35994.000000 shares for an estimated $664550.02. Reported holdings after the transaction were 88033.000000 shares. The stored filing text includes a detected 10b5-1 reference.
- Trade date
- Sep 09, 2026
- Filing date
- Sep 18, 2026
How reported position traded is calculated
Shares sold ÷ (holdings after + shares sold). Estimated position before: 124,027 shares.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
Filing warnings
Notes recorded with this filingBBNX price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- Sell Code S
- Identifier
- 0002048497-26-000016 Common Stock
- Transaction date
- Sep 09, 2026 Filed Sep 18, 2026, 11:51 PM · 9d delay
- Shares
- 35,994 sh $18.46 per share
- Estimated value
- -$664k Computed from shares × price
- Holdings after
- 88,033 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-16 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - tenb5_1_detected-10 points
is_10b5_1 = true
Stored filing content includes detected 10b5-1 language. - amended_filing-6 points
is_amendment = true
Amended filing: the original transaction may have been restated. - delayed_filing-6 points
reporting_delay_days = 9
Filing delay exceeds the configured threshold.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
Chief Commercial Officer
- F1
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026 (the "10b5-1 Plan").
- F2
On September 10, 2026, the reporting person filed a Form 4 which incorrectly reported the number of shares disposed. The reporting person sold 35,994 shares under the 10b5-1 Plan on September 9, 2026…
0 other transactions
0 recent txs